We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close
Focus On
NEW In-House Counsel | Insurance | Intellectual Property | Immigration | Natural Resources | Real Estate | Tax

Intellectual Property Law - Patents - Procedure - Judicial review - Grounds

Thursday, November 10, 2016 @ 7:00 PM  

Appeals by two generic drug manufacturers, the Attorney General and the Minister of Health from orders setting aside Notices of Compliance (NOC) issued by the Minister. The Minister issued a NOC to Teva Canada Limited (Teva) for its generic version of exemestane tablets. Pfizer Canada Inc. (Pfizer), who marketed exemestane tablets under the brand name AROMASIN, challenged the Minister’s decision to issue the NOC to Teva. A judge of the Federal Court found that the standard of review of the Minister’s decision was correctness. The Federal...